File(s) under permanent embargo
Nilotinib induces deeper molecular responses vs continued imatinib in patients with ph+ chronic myeloid leukemia (CML) with detectable disease after ≥ 2 years on imatinib: ENESTcmr 12-months results
journal contribution
posted on 2012-06-01, 00:00 authored by C Cervantes, T Hughes, G Etienne, C De Souza, P Dorlhiac Llacer, A Schwarer, B Leber, J Lipton, N Spector, John Reynolds, L Collins, T Szczudlo, D ReaNilotinib induces deeper molecular responses vs continued imatinib in patients with ph+ chronic myeloid leukemia (CML) with detectable disease after ≥ 2 years on imatinib: ENESTcmr 12-months results
History
Journal
HaematologicaVolume
97Issue
Supp 1Season
Abstract #0586Pagination
239 - 239Publisher
Ferrata Storti FoundationLocation
Pavia, ItalyISSN
0390-6078eISSN
1592-8721Language
engNotes
Oral presentation; Abstract book for European Hematology Association. Congress (17th : 2010 : Amsterdam, The Netherlands) held from 14 - 17 Jun. 2012Publication classification
C2.1 Other contribution to refereed journalUsage metrics
Categories
No categories selectedLicence
Exports
RefWorks
BibTeX
Ref. manager
Endnote
DataCite
NLM
DC